Key result
Mitral valve repair in patients with infective endocarditis is feasible and associated with low morbidity, with no cases of recurrent infection observed during follow-up.
Why the study?
Is mitral valve repair feasible and safe compared to valve replacement in patients with infective endocarditis?
Observational (n=21)
No
Is mitral valve repair feasible and safe compared to valve replacement in patients with infective endocarditis?
Answers are grounded in this paper and cite their sources.
Mitral valve repair is a feasible surgical option with low morbidity and acceptable durability for selected patients with active or healed infective endocarditis.
BACKGROUND: The goal of the present study was to investigate the feasibility of mitral valvle repair in patients with infective endocarditis (IE). METHODS AND RESULTS: Twenty-one patients who had undergone mitral valve surgery for IE were reviewed. Valve repair was performed in 8 patients with active and in 6 patients with healed endocarditis: 6 of these 14 patients were New York Heart Association (NYHA) functional class III or IV preoperatively. Valve replacement was performed in 5 patients with active endocarditis and in 2 with healed endocarditis: 6 of these 7 patients were NYHA functional class III or IV preoperatively. Repair techniques included annuloplasty (n=13), resection-suture (n=13), chordal transfer (n=2), and closure of the perforation (n=3). In the valve replacement group, 6 patients required concomitant aortic valve replacement. In the valve repair group, 1 patient died and 1 patient required reoperation for recurrent mitral regurgitation. Postoperative echocardiography demonstrated no (n=8) or mild (n=4) mitral regurgitation at the last follow-up examination. In the valve replacement group, 1 patient died and 1 patient required reoperation because of a paravalvular leak. No cases of recurrent infection occurred in either group. CONCLUSIONS: Mitral valve repair in patients with IE is feasible and has low morbidity.
No takes yet. Share an insight, caveat, or question.
Yamaguchi et al. (2006) conducted an observational in Infective endocarditis affecting the mitral valve (n=21). Mitral valve repair vs. Mitral valve replacement was evaluated on Feasibility, mortality, and morbidity. Mitral valve repair in patients with infective endocarditis is feasible and associated with low morbidity, with no cases of recurrent infection observed during follow-up.
Synapse has enriched 10 related papers. Consider them for comparative context: